SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-077271
Filing Date
2022-03-16
Accepted
2022-03-16 16:25:16
Documents
6
Effectiveness Date
2022-03-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-8 d331239ds8.htm S-8 44311
2 EX-5.1 d331239dex51.htm EX-5.1 12434
3 EX-23.1 d331239dex231.htm EX-23.1 1182
4 EX-FILING FEES d331239dexfilingfees.htm EX-FILING FEES 14601
5 GRAPHIC g331239dsp0001.jpg GRAPHIC 3099
6 GRAPHIC g331239g0315234902616.jpg GRAPHIC 1785
  Complete submission text file 0001193125-22-077271.txt   80617
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263611 | Film No.: 22745201
SIC: 2834 Pharmaceutical Preparations